Incident hyperglycaemia among older adults with or at-risk for HIV infection

Sarit Polsky, Michelle Floris-Moore, Ellie Schoenbaum, Robert S. Klein, Julia H. Arnsten, Andrea A. Howard

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: HIV infection has been associated with development of prediabetes and diabetes. Optimum screening practices for these disorders in HIV-infected populations remain unclear. Methods: We screened 377 adults, with or at-risk for HIV infection, for incident hyperglycaemia (prediabetes or diabetes) using two oral glucose tolerance tests (OGTTs) a median of 18.6 months apart. We determined proportion of incident cases detected by fasting and 120-min plasma glucose levels. Independent predictors of incident hyperglycaemia were identified using logistic regression. Results: The baseline OGTT was consistent with diabetes in 7% of participants and with prediabetes in 31%. Among 352 normoglycaemic and prediabetic participants at baseline, 19 (5%) developed diabetes on follow-up. Among participants normoglycaemic at baseline, an additional 38 (16%) developed prediabetes. Overall 52% of incident hyperglycaemia cases were detected by fasting plasma glucose alone, 33% by a 120-min glucose level alone and 15% by both. Factors independently associated with incident hyperglycaemia included age ≥50 years and body mass index ≥30 kg/m2. Neither HIV infection nor highly active antiretroviral therapy (HAART) use were associated with increased risk of diabetes. Conclusions: Incident hyperglycaemia is common among older adults with or at-risk for HIV infection. HIV-infected individuals with classic diabetes risk factors should be screened for hyperglycaemia regardless of HAART use. OGTTs might be the preferred screening strategy in HIV-infected individuals at high risk for developing hyperglycaemia.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalAntiviral Therapy
Volume16
Issue number2
DOIs
StatePublished - 2011

Fingerprint

Hyperglycemia
HIV Infections
Prediabetic State
Glucose Tolerance Test
Highly Active Antiretroviral Therapy
HIV
Glucose
Fasting
Body Mass Index
Logistic Models
Population

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Incident hyperglycaemia among older adults with or at-risk for HIV infection. / Polsky, Sarit; Floris-Moore, Michelle; Schoenbaum, Ellie; Klein, Robert S.; Arnsten, Julia H.; Howard, Andrea A.

In: Antiviral Therapy, Vol. 16, No. 2, 2011, p. 181-188.

Research output: Contribution to journalArticle

Polsky, Sarit ; Floris-Moore, Michelle ; Schoenbaum, Ellie ; Klein, Robert S. ; Arnsten, Julia H. ; Howard, Andrea A. / Incident hyperglycaemia among older adults with or at-risk for HIV infection. In: Antiviral Therapy. 2011 ; Vol. 16, No. 2. pp. 181-188.
@article{bb3d015cdb4348b6b7c54c74581f8fef,
title = "Incident hyperglycaemia among older adults with or at-risk for HIV infection",
abstract = "Background: HIV infection has been associated with development of prediabetes and diabetes. Optimum screening practices for these disorders in HIV-infected populations remain unclear. Methods: We screened 377 adults, with or at-risk for HIV infection, for incident hyperglycaemia (prediabetes or diabetes) using two oral glucose tolerance tests (OGTTs) a median of 18.6 months apart. We determined proportion of incident cases detected by fasting and 120-min plasma glucose levels. Independent predictors of incident hyperglycaemia were identified using logistic regression. Results: The baseline OGTT was consistent with diabetes in 7{\%} of participants and with prediabetes in 31{\%}. Among 352 normoglycaemic and prediabetic participants at baseline, 19 (5{\%}) developed diabetes on follow-up. Among participants normoglycaemic at baseline, an additional 38 (16{\%}) developed prediabetes. Overall 52{\%} of incident hyperglycaemia cases were detected by fasting plasma glucose alone, 33{\%} by a 120-min glucose level alone and 15{\%} by both. Factors independently associated with incident hyperglycaemia included age ≥50 years and body mass index ≥30 kg/m2. Neither HIV infection nor highly active antiretroviral therapy (HAART) use were associated with increased risk of diabetes. Conclusions: Incident hyperglycaemia is common among older adults with or at-risk for HIV infection. HIV-infected individuals with classic diabetes risk factors should be screened for hyperglycaemia regardless of HAART use. OGTTs might be the preferred screening strategy in HIV-infected individuals at high risk for developing hyperglycaemia.",
author = "Sarit Polsky and Michelle Floris-Moore and Ellie Schoenbaum and Klein, {Robert S.} and Arnsten, {Julia H.} and Howard, {Andrea A.}",
year = "2011",
doi = "10.3851/IMP1711",
language = "English (US)",
volume = "16",
pages = "181--188",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "2",

}

TY - JOUR

T1 - Incident hyperglycaemia among older adults with or at-risk for HIV infection

AU - Polsky, Sarit

AU - Floris-Moore, Michelle

AU - Schoenbaum, Ellie

AU - Klein, Robert S.

AU - Arnsten, Julia H.

AU - Howard, Andrea A.

PY - 2011

Y1 - 2011

N2 - Background: HIV infection has been associated with development of prediabetes and diabetes. Optimum screening practices for these disorders in HIV-infected populations remain unclear. Methods: We screened 377 adults, with or at-risk for HIV infection, for incident hyperglycaemia (prediabetes or diabetes) using two oral glucose tolerance tests (OGTTs) a median of 18.6 months apart. We determined proportion of incident cases detected by fasting and 120-min plasma glucose levels. Independent predictors of incident hyperglycaemia were identified using logistic regression. Results: The baseline OGTT was consistent with diabetes in 7% of participants and with prediabetes in 31%. Among 352 normoglycaemic and prediabetic participants at baseline, 19 (5%) developed diabetes on follow-up. Among participants normoglycaemic at baseline, an additional 38 (16%) developed prediabetes. Overall 52% of incident hyperglycaemia cases were detected by fasting plasma glucose alone, 33% by a 120-min glucose level alone and 15% by both. Factors independently associated with incident hyperglycaemia included age ≥50 years and body mass index ≥30 kg/m2. Neither HIV infection nor highly active antiretroviral therapy (HAART) use were associated with increased risk of diabetes. Conclusions: Incident hyperglycaemia is common among older adults with or at-risk for HIV infection. HIV-infected individuals with classic diabetes risk factors should be screened for hyperglycaemia regardless of HAART use. OGTTs might be the preferred screening strategy in HIV-infected individuals at high risk for developing hyperglycaemia.

AB - Background: HIV infection has been associated with development of prediabetes and diabetes. Optimum screening practices for these disorders in HIV-infected populations remain unclear. Methods: We screened 377 adults, with or at-risk for HIV infection, for incident hyperglycaemia (prediabetes or diabetes) using two oral glucose tolerance tests (OGTTs) a median of 18.6 months apart. We determined proportion of incident cases detected by fasting and 120-min plasma glucose levels. Independent predictors of incident hyperglycaemia were identified using logistic regression. Results: The baseline OGTT was consistent with diabetes in 7% of participants and with prediabetes in 31%. Among 352 normoglycaemic and prediabetic participants at baseline, 19 (5%) developed diabetes on follow-up. Among participants normoglycaemic at baseline, an additional 38 (16%) developed prediabetes. Overall 52% of incident hyperglycaemia cases were detected by fasting plasma glucose alone, 33% by a 120-min glucose level alone and 15% by both. Factors independently associated with incident hyperglycaemia included age ≥50 years and body mass index ≥30 kg/m2. Neither HIV infection nor highly active antiretroviral therapy (HAART) use were associated with increased risk of diabetes. Conclusions: Incident hyperglycaemia is common among older adults with or at-risk for HIV infection. HIV-infected individuals with classic diabetes risk factors should be screened for hyperglycaemia regardless of HAART use. OGTTs might be the preferred screening strategy in HIV-infected individuals at high risk for developing hyperglycaemia.

UR - http://www.scopus.com/inward/record.url?scp=79953190406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953190406&partnerID=8YFLogxK

U2 - 10.3851/IMP1711

DO - 10.3851/IMP1711

M3 - Article

C2 - 21447867

AN - SCOPUS:79953190406

VL - 16

SP - 181

EP - 188

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -